Case Report: Presenting as optic neuritis—a biopsy-proven IgG4 anti-NF155–positive combined central and peripheral demyelination syndrome - Report - MDSpire

Case Report: Presenting as optic neuritis—a biopsy-proven IgG4 anti-NF155–positive combined central and peripheral demyelination syndrome

  • By

  • Yujing Peng

  • Xiaonan Wang

  • Weijiao Zhang

  • Ran Li

  • Jingting Peng

  • Jiawei Wang

  • Hanqiu Jiang

  • May 22, 2026

  • 0 min

Share

Clinical Report: Optic Neuritis as Initial Presentation of IgG4 Anti-NF155-Positive CCPD

Overview

This case study presents a young male with severe optic neuritis as the initial manifestation of biopsy-confirmed combined central and peripheral demyelination (CCPD) associated with anti-NF155 antibodies. The findings emphasize the importance of anti-NF155 antibody testing in patients with optic neuritis and peripheral neuropathy.

Background

Combined central and peripheral demyelination (CCPD) is a rare neuroimmune disorder characterized by concurrent demyelination in both the central and peripheral nervous systems. The clinical manifestations can vary widely, and optic neuritis may be an initial presentation. Identifying specific autoantibodies, such as IgG4 anti-NF155, is crucial for diagnosis and management.

Data Highlights

No numerical data or trial data provided in the article.

Key Findings

  • A 21-year-old male presented with severe optic neuritis and was positive for anti-NF155 antibodies.
  • His clinical course included steroid dependence and relapse upon treatment discontinuation.
  • Histopathological examination confirmed the diagnosis of CCPD.
  • Initial treatment with intravenous methylprednisolone showed limited efficacy on visual impairment.
  • Sustained remission was achieved with corticosteroid pulse therapy combined with rituximab.

Clinical Implications

The case highlights the need for anti-NF155 antibody testing in patients presenting with optic neuritis and peripheral neuropathy. Effective management strategies may require aggressive immunomodulation, particularly in cases resistant to standard treatments.

Conclusion

This case underscores the potential for optic neuritis to be the initial manifestation of CCPD and the importance of timely diagnosis and treatment.

Related Resources & Content

  1. Hypertrophic Pachymeningitis Associated with IgG4-Related Disease Featuring Tumor-like Lesions in the Brain, 2022
  2. Pathological Insights into Inflammatory Demyelinating Disorders of the Central Nervous System Associated with Myelin Oligodendrocyte Glycoprotein Autoantibodies, 2020
  3. Neuromyelitis optica spectrum disorder with painful tonic spasms as the first symptom: a case report, 2026
  4. Clinical and electrophysiological features of adult patients with combined central and peripheral demyelination- a systematic review, 2025
  5. Blood Cancer Journal — Characteristics and Prognostic Outcomes of Histiocytic Neoplasms in the Central Nervous System
  6. Frontiers | Clinical and electrophysiological features of adult patients with combined central and peripheral demyelination- a systematic review
  7. Evaluation and treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy | BMJ Neurology Open
  8. Optic Neuritis - PubMed

Original Source(s)

Related Content